breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Marginal read alignment evidence (highest frequency 20 of 53 shown, sorted by frequency from high to low) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
* | NZ_CP009273 | 3,774,215 | 0 | T | G | 61.8% | 18.9 / 29.9 | 34 | G343G (GGT→GGG) | lldD | quinone‑dependent L‑lactate dehydrogenase |
* | NZ_CP009273 | 4,213,525 | 0 | C | T | 61.5% | ‑5.1 / 11.5 | 13 | R11K (AGA→AAA) | iclR | glyoxylate bypass operon transcriptional repressor IclR |
* | NZ_CP009273 | 4,594,161 | 0 | C | T | 59.5% | 4.2 / 44.3 | 37 | S62F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
* | NZ_CP009273 | 4,464,532 | 0 | T | G | 56.2% | 22.8 / 27.0 | 32 | *198G (TGA→GGA) | bdcR | TetR/AcrR family transcriptional regulator |
* | NZ_CP009273 | 3,659,062 | 0 | C | A | 55.6% | 14.7 / 40.3 | 27 | A37S (GCG→TCG) | gadX | acid resistance transcriptional activator GadX |
* | NZ_CP009273 | 1,733,821 | 0 | T | G | 55.0% | 16.0 / 22.5 | 21 | T79P (ACC→CCC) | punR | DNA‑binding transcriptional activator PunR |
* | NZ_CP009273 | 832,042 | 0 | C | G | 54.5% | 7.2 / 26.5 | 22 | A79G (GCG→GGG) | hcxB | hydroxycarboxylate dehydrogenase HcXB |
* | NZ_CP009273 | 1,408,014 | 0 | A | T | 54.5% | 6.1 / 13.2 | 11 | N57K (AAT→AAA) | ralR | type I toxin‑antitoxin system endodeoxyribonuclease toxin RalR |
* | NZ_CP009273 | 1,429,982 | 0 | C | A | 54.5% | 4.7 / 17.1 | 11 | intergenic (‑106/+35) | uspF/ompN | universal stress protein UspF/porin OmpN |
* | NZ_CP009273 | 1,429,984 | 0 | G | A | 54.5% | 0.2 / 11.9 | 11 | intergenic (‑108/+33) | uspF/ompN | universal stress protein UspF/porin OmpN |
* | NZ_CP009273 | 4,091,432 | 0 | T | G | 54.5% | 9.3 / 12.1 | 11 | intergenic (+74/‑186) | sodA/kdgT | superoxide dismutase [Mn]/2‑keto‑3‑deoxygluconate transporter |
* | NZ_CP009273 | 3,738,379 | 0 | C | G | 54.2% | ‑2.3 / 10.3 | 24 | G72G (GGC→GGG) | yiaN | 2,3‑diketo‑L‑gulonate transporter large permease YiaN |
* | NZ_CP009273 | 4,213,521 | 0 | T | G | 53.8% | 8.0 / 16.3 | 13 | K12N (AAA→AAC) | iclR | glyoxylate bypass operon transcriptional repressor IclR |
* | NZ_CP009273 | 2,367,400 | 0 | A | C | 53.6% | 24.6 / 32.2 | 28 | G361G (GGT→GGG) | menE | o‑succinylbenzoate‑‑CoA ligase |
* | NZ_CP009273 | 256,937 | 0 | T | G | 53.3% | 11.3 / 14.6 | 15 | V280G (GTA→GGA) | proB | glutamate 5‑kinase |
* | NZ_CP009273 | 595,032 | 0 | T | G | 53.3% | ‑0.1 / 16.7 | 15 | V288G (GTG→GGG) | cusA | Cu(+)/Ag(+) efflux RND transporter permease subunit CusA |
* | NZ_CP009273 | 700,026 | 0 | T | G | 53.3% | 10.6 / 17.5 | 15 | G209G (GGT→GGG) | nagE | PTS N‑acetyl glucosamine transporter subunit IIABC |
* | NZ_CP009273 | 1,152,727 | 0 | T | G | 53.3% | 13.3 / 20.0 | 15 | G165G (GGT→GGG) | ycfH | metal‑dependent hydrolase |
* | NZ_CP009273 | 2,611,050 | 0 | A | C | 53.3% | 13.2 / 17.5 | 15 | T38T (ACA→ACC) | arsC | arsenate reductase (glutaredoxin) |
* | NZ_CP009273 | 3,126,661 | 0 | T | G | 53.3% | 9.1 / 20.0 | 15 | H219P (CAC→CCC) | yghS | dTMP kinase |